COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35404416.
- Also identified by DOI 10.1001/jamainternmed.2022.0761 and PMC identifier 9002709.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This survey study assesses vaccination intentions of unvaccinated US adults in response to full US Food and Drug Administration (FDA) approval of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine and any demographic characteristics associated with those intentions.
Medical subject headings
- COVID-19
- COVID-19 Vaccines